Showcases Stock ranks

Sorrento Therpt (SRNE)
13.785  0.945 (7.36%) 08-05 16:00
Open: 14.31 Pre. Close: 12.84
High: 14.55 Low: 12.3
Volume: 147,027,366 Market Cap: 3,336M
Sorrento Therapeutics, Inc., a clinical stage biopharma company, develops therapies for cancer, autoimmune, inflammatory, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutics by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugates, as well as bispecific antibody approaches. It also offers Sofusa, a drug delivery technology that delivers biologics directly into the lymphatic system. In addition, the company's clinical programs in development include anti-CD38 CAR-T therapy for the treatment of multiple myeloma, as well as for amyloidosis and graft-versus-host diseases.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 14.559 - 14.602 14.602 - 14.65
Low: 12.186 - 12.232 12.232 - 12.283
Close: 13.691 - 13.767 13.767 - 13.853
Stock Technical Analysis
Target: Six months: 16.99
One year: 19.85
Support: Support1: 9.28
Support2: 6.02
Resistance: Resistance1: 14.55
Resistance2: 16.99
Pivot: 8.70
Moving Averages: MA(5): 10.77
MA(20): 8.42
MA(100): 4.68
MA(250): 3.42
MACD: MACD(12,26): 1.35
Signal(12,26,9): 0.85
%K %D: %K(14,3): 89.25
%D(3): 83.67
RSI: RSI(14): 83.16
52-Week: High: 14.55
Low: 1.39
Change(%): 526.6
Average Vol(K): 3-Month: 4625758
10-Days: 5341024
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.

SRNE has closed above the upper band by 14.8%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 246.6% wider than normal. The large width of the bands suggest high volatility as compared to SRNE's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.
Stock chart
Stock News
Tue, 04 Aug 2020
3 Key Questions to Answer Before Buying Sorrento Therapeutics Stock - InvestorPlace

Wed, 29 Jul 2020
Sorrento jumps 4.5% after licensing rapid COVID-19 test from Columbia - Seeking Alpha

Tue, 28 Jul 2020
Vision of a Covid-19 Breakthrough Makes Sorrento Therapeutics Stock a Buy -

Mon, 27 Jul 2020
Moderna's Patent Snub, And Other News: The Good, Bad And Ugly Of Biopharma - Seeking Alpha

Mon, 27 Jul 2020
Why Sorrento Therapeutics Stock Is Jumping Today - Motley Fool

Fri, 24 Jul 2020
Sorrento to acquire COVID-19 therapy developer - Seeking Alpha

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 209.69
Shares Float (M) 144.99
% Held by Insiders 34.21
% Held by Institutions 17.86
Shares Short (K) 50080
Shares Short Prior Month (K) 37060
Stock Financials
EPS -1.950
Book Value (p.s.) 0.510
Profit Margin
Operating Margin -577.03
Return on Assets (ttm) -20.8
Return on Equity (ttm) -337.4
Qtrly Rev. Growth 25.7
Gross Profit (p.s.) -0.418
Sales Per Share 0.157
EBITDA (p.s.) -0.858
Qtrly Earnings Growth
Operating Cash Flow (M) -167.24
Levered Free Cash Flow (M) -114.95
Stock Valuation
PE Ratio -7.07
PEG Ratio
Price to Book value 27.03
Price to Sales 87.57
Price to Cash Flow -17.28
Stock Dividends
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator